Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Prospective, multicenter, phase IV, open, randomized, parallel, controlled, in which 288 (two
hundred and eighty-eight) participants of both sexes, aged between 40 and 75 years will be
randomly allocated to one of two treatment groups , and treatment group 01 will be the dried
extract of Curcuma longa complexed with phosphatidylcholine (Motore®), and treatment group 02
will ibuprofen (Alivium®).